Results 141 to 150 of about 24,233 (282)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Editorial: From Thinker to Doer: Creativity, Innovation, Entrepreneurship, Maker, and Venture Capital. [PDF]

Front Psychol, 2021
Wu YJ, Yuan CH, Chen MY.
europepmc   +1 more source

Development in South Africa and Venture Capital: The Challenges and Opportunities for the Enterprise Fund for Southern Africa

, 1997
Rafael X. Zahralddin-Aravena
openalex   +1 more source

The impacts of biological invasions

Biological Reviews, EarlyView.
ABSTRACT The Anthropocene is characterised by a continuous human‐mediated reshuffling of the distributions of species globally. Both intentional and unintentional introductions have resulted in numerous species being translocated beyond their native ranges, often leading to their establishment and subsequent spread – a process referred to as biological
Phillip J. Haubrock, Teun Everts, Neil Angelo S. Abreo, Jamie Bojko, Victor Deklerck, James W. E. Dickey, Ana Clara S. Franco, Emili García‐Berthou, Stelios Katsanevakis, Natalia I. Kirichenko, Stefano Mammola, Martin A. Nuñez, Ben Parker, Riccardo Scalera, Ismael Soto, Diederik Strubbe, Ali Serhan Tarkan, Lorenzo Vilizzi, Tim Adriaens, Paride Balzani, Dagmara Błońska, Elizabeta Briski, Rein Brys, Amy L. Burgess, James E. Byers, Carlos Cano‐Barbacil, Giuseppe Castaldelli, Jaimie T.A. Dick, Victoria Dominguez Almela, Romina D. Dimarco, Margarita Florencio, Antonín Kouba, Melina Kourantidou, Irmak Kurtul, Irene Martín‐Forés, Olivier Morissette, Julian D. Olden, Bruno E. Soares, Jakub Truszkowski, Hugo Verreycken, Marc Kenis, Ronaldo Sousa, J. Robert Britton   +42 more
wiley   +1 more source

Global venture capital flows and US health care innovation. [PDF]

Health Aff Sch
Ji Y, Kang SY.
europepmc   +1 more source

Institutional Entrepreneurship and Work for Enhanced Sustainability at the Base of the Pyramid

Business Strategy and the Environment, EarlyView.
ABSTRACT Promoting sustainability at the base of the pyramid (BoP) often falls short of inclusive development due to informal and fragmented institutions, creating institutional voids. Although institutions are critical in BoP settings, there is limited clarity on how institutional mechanisms can address sustainability challenges in low‐income contexts
Nikolas K. Kelling, Sadaat Ali Yawar, Stefan Gold   +2 more
wiley   +1 more source

The Inflation Reduction Act's Impact Upon Early-Stage Venture Capital Investments. [PDF]

Ther Innov Regul Sci
Schulthess DG, O'Loughlin G, Askeland M, Gassull D, Bowen HP.   +4 more
europepmc   +1 more source

Green Banking Practices, Social, Health and Environmental Disclosures and Bank Financial Performance: The Role of Innovations and Corporate Governance

Business Strategy and the Environment, EarlyView.
ABSTRACT Regulators in the banking industry in the Sub‐Saharan Africa (SSA) region are progressively concentrating on corporate innovation and bank social, health and environmental disclosures (BSHED) as crucial corporate governance (CG) structures to improve bank financial performance (BFP).
Douglas A. Adu, Musa Mangena, Emmanuel Adegbite, Frank Boateng   +3 more
wiley   +1 more source